Clinical trials
Terminated Phase 1 Carcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 3 |
| 2009 | 3 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 3 |
| 2017 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 24 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Blueprint Medicines Corporation | 3 |
| Astellas Pharma Inc | 2 |
| National Cancer Institute (NCI) | 2 |
| Amgen | 1 |
| Celgene | 1 |
| Dynavax Technologies Corporation | 1 |
| Genocea Biosciences, Inc. | 1 |
| German Cancer Research Center | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| Julie E. Bauman, MD, MPH | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma | 24 |
| Neoplasms | 13 |
| Adenocarcinoma | 7 |
| Carcinoma, Non-Small-Cell Lung | 6 |
| Lung Neoplasms | 5 |
| Neoplasm Metastasis | 5 |
| Neoplasms by Histologic Type | 5 |
| Neoplasms by Site | 4 |
| Ovarian Neoplasms | 4 |
| Squamous Cell Carcinoma of Head and Neck | 4 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.